Clover Health Investments (CLOV) Share-based Compensation (2020 - 2026)

Clover Health Investments (CLOV) has 7 years of Share-based Compensation data on file, last reported at $12.3 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 53.58% year-over-year to $12.3 million; the trailing twelve-month figure through Mar 2026 stood at $89.5 million (down 20.08% YoY), and the FY2025 full-year result was $103.7 million, down 9.34% from the prior year.
• Share-based Compensation for Q1 2026 stood at $12.3 million, down from $24.9 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $42.6 million in Q3 2022 and bottomed at $12.3 million in Q1 2026.
• The 5-year median for Share-based Compensation is $29.6 million (2024), against an average of $31.5 million.
• The widest annual swing landed in 2022, when Share-based Compensation gained 25.38%; it then sank 53.58% in 2026.
• A 5-year view of Share-based Compensation shows it stood at $39.1 million in 2022, then decreased by 15.24% to $33.1 million in 2023, then slipped by 10.54% to $29.6 million in 2024, then dropped by 15.94% to $24.9 million in 2025, then slumped by 50.76% to $12.3 million in 2026.
• The last three Share-based Compensation figures came in at $12.3 million (Q1 2026), $24.9 million (Q4 2025), and $26.1 million (Q3 2025), per Business Quant data.

Peer Comparison